These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial. Kufner S; Byrne RA; Valeskini M; Schulz S; Ibrahim T; Hoppmann P; Schneider S; Laugwitz KL; Schunkert H; Kastrati A; EuroIntervention; 2016 Mar; 11(12):1372-9. PubMed ID: 25405657 [TBL] [Abstract][Full Text] [Related]
6. In-vitro mechanical behavior and in-vivo healing response of a new generation biodegradable polymer-coated thin-strut sirolimus-eluting stents. Gąsior P; Pyka Ł; Hawranek M; Garbacz M; Chagnon M; Beaudry D; Fluder J; Gąsior M; Wojakowski W; Lekston A Kardiol Pol; 2022; 80(1):72-75. PubMed ID: 34775590 [No Abstract] [Full Text] [Related]
7. A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial. Gao RL; Xu B; Lansky AJ; Yang YJ; Ma CS; Han YL; Chen SL; Li H; Zhang RY; Fu GS; Yuan ZY; Jiang H; Huo Y; Li W; Zhang YJ; Leon MB; EuroIntervention; 2013 May; 9(1):75-83. PubMed ID: 23685298 [TBL] [Abstract][Full Text] [Related]
8. Comparison of abluminal biodegradable polymer biolimus-eluting stents and durable polymer everolimus-eluting stents in the treatment of coronary bifurcations. Costopoulos C; Latib A; Naganuma T; Sticchi A; Ferrarello S; Regazzoli D; Chieffo A; Figini F; Carlino M; Montorfano M; Naim C; Kawaguchi M; Gerasimou A; Giannini F; Godino C; Colombo A Catheter Cardiovasc Interv; 2014 May; 83(6):889-95. PubMed ID: 23804318 [TBL] [Abstract][Full Text] [Related]
9. Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial. Teeuwen K; van der Schaaf RJ; Adriaenssens T; Koolen JJ; Smits PC; Henriques JP; Vermeersch PH; Tjon Joe Gin RM; Schölzel BE; Kelder JC; Tijssen JG; Agostoni P; Suttorp MJ JACC Cardiovasc Interv; 2017 Jan; 10(2):133-143. PubMed ID: 28104206 [TBL] [Abstract][Full Text] [Related]
10. Five-year outcome of a randomised trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: the NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial (NEXT). Natsuaki M; Kozuma K; Morimoto T; Kadota K; Muramatsu T; Nakagawa Y; Akasaka T; Hanaoka KI; Tanabe K; Morino Y; Nishikawa H; Kimura T EuroIntervention; 2018 Sep; 14(7):815-818. PubMed ID: 29437036 [No Abstract] [Full Text] [Related]
11. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698 [TBL] [Abstract][Full Text] [Related]
12. Bioresorbable polymer drug-eluting stents. Shah R Lancet; 2018 Mar; 391(10124):935-936. PubMed ID: 29536854 [No Abstract] [Full Text] [Related]
16. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial. Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234 [TBL] [Abstract][Full Text] [Related]
17. Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial. Slagboom T; Toelg R; Witzenbichler B; Haude M; Masotti M; Ruiz Salmeron R; Witkowski AR; Uematus M; Takahashi A; Waksman R; Saito S EuroIntervention; 2023 Feb; 18(14):1197-1200. PubMed ID: 36625005 [No Abstract] [Full Text] [Related]
18. Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trial. Pilgrim T; Roffi M; Tüller D; Muller O; Vuilliomenet A; Cook S; Weilenmann D; Kaiser C; Jamshidi P; Heg D; Jüni P; Windecker S Am Heart J; 2014 Sep; 168(3):256-61. PubMed ID: 25173535 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies). Lansky AJ; Kastrati A; Edelman ER; Parise H; Ng VG; Ormiston J; Wijns W; Byrne RA Am J Cardiol; 2016 Feb; 117(4):532-538. PubMed ID: 26762729 [TBL] [Abstract][Full Text] [Related]
20. Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial. Jensen LO; Thayssen P; Maeng M; Ravkilde J; Krusell LR; Raungaard B; Junker A; Terkelsen CJ; Veien KT; Villadsen AB; Kaltoft A; Tilsted HH; Hansen KN; Aaroe J; Kristensen SD; Hansen HS; Jensen SE; Madsen M; Bøtker HE; Berencsi K; Lassen JF; Christiansen EH Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]